v3.25.1
Condensed Consolidated Statements of Equity (Deficit) (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023 115,000        
Beginning balance at Dec. 31, 2023 $ 117,638        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Dividends accrued - Convertible Preferred Stock $ 1,375        
Ending balance (in shares) at Mar. 31, 2024 115,000        
Ending balance at Mar. 31, 2024 $ 119,013        
Beginning balance (in shares) at Dec. 31, 2023   29,908,407      
Beginning balance at Dec. 31, 2023 126,294 $ 3 $ 608,995 $ 6,168 $ (488,872)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Dividends accrued - Convertible Preferred Stock (1,375)   (1,375)    
Issuance of stock under Company plans, net of shares withheld for tax (in shares)   330,903      
Issuance of stock under Company plans, net of shares withheld for tax (331)   (331)    
Stock repurchases and retirements (in shares)   (2,242,654)      
Stock repurchases and retirements (7,998)   (7,998)    
Stock-based compensation 3,522   3,522    
Unrealized foreign currency translation adjustment (2,611)        
Foreign currency translation adjustment (2,611)     (2,611)  
Realized foreign currency translation from divestitures of businesses 0        
Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries (1,412)     (1,412)  
Interest rate swaps 162     162  
Net loss (96,130)       (96,130)
Ending balance (in shares) at Mar. 31, 2024   27,996,656      
Ending balance at Mar. 31, 2024 $ 20,121 $ 3 602,813 2,307 (585,002)
Beginning balance (in shares) at Dec. 31, 2024 115,000        
Beginning balance at Dec. 31, 2024 $ 123,230        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Dividends accrued - Convertible Preferred Stock $ 1,438        
Ending balance (in shares) at Mar. 31, 2025 115,000        
Ending balance at Mar. 31, 2025 $ 124,668        
Beginning balance (in shares) at Dec. 31, 2024 28,168,267 28,168,267      
Beginning balance at Dec. 31, 2024 $ (18,305) $ 3 605,286 (21,990) (601,604)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Dividends accrued - Convertible Preferred Stock (1,438)   (1,438)    
Issuance of stock under Company plans, net of shares withheld for tax (in shares)   316,012      
Issuance of stock under Company plans, net of shares withheld for tax (494)   (494)    
Stock-based compensation 2,675   2,675    
Unrealized foreign currency translation adjustment 2,264     2,264  
Realized foreign currency translation from divestitures of businesses 5,715     5,715  
Unrealized translation gain (loss) on intercompany loans with foreign subsidiaries 1,498     1,498  
Interest rate swaps (3,890)     (3,890)  
Net loss $ (25,848)       (25,848)
Ending balance (in shares) at Mar. 31, 2025 28,484,279 28,484,279      
Ending balance at Mar. 31, 2025 $ (37,823) $ 3 $ 606,029 $ (16,403) $ (627,452)